TerrAscend (TSNDF) Change in Receivables (2021 - 2026)
TerrAscend (TSNDF) posted quarterly Change in Receivables of -$1.1 million for Q1 2026, up 46.2% year-over-year from -$754471.1 in Q1 2025, and down 351.83% quarter-over-quarter from $438000.0 in Q4 2025.
TerrAscend (TSNDF) Change in Receivables (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Change in Receivables for 6 consecutive years, with -$1.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Receivables rose 46.2% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at -$699000.0 (down 113.43% YoY), while the FY2025 annual figure was -$1.6 million, down 131.04% from the prior year.
- Change in Receivables declined to -$1.1 million in Q1 2026 per TSNDF's latest filing, from $438000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $6.0 million in Q4 2024 and bottomed at -$3.2 million in Q3 2022.
- Historically, Change in Receivables has averaged $492117.6 across 5 years, with a median of $437000.0 in 2024.
- Annual changes were most pronounced in 2023 — Change in Receivables soared 3810.75% — and 2025, when it plunged 406.74%.
- TerrAscend's Change in Receivables stood at -$93000.0 in 2022, then jumped by 3810.75% to $3.5 million in 2023, then soared by 73.08% to $6.0 million in 2024, then sank by 92.67% to $438000.0 in 2025, then sank by 351.83% to -$1.1 million in 2026.
- Business Quant data shows TSNDF's Change in Receivables at -$1.1 million in Q1 2026, $438000.0 in Q4 2025, and -$2.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn | 1.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.37 Mn |
| Jun 30, 2026 | 1.37 Mn |
| Mar 31, 2026 | -1.10 Mn |
| Mar 31, 2026 | -1.10 Mn |
| Dec 31, 2025 | 438,000.00 |
| Dec 31, 2025 | 438,000.00 |
| Sep 30, 2025 | -2.60 Mn |
| Sep 30, 2025 | -2.60 Mn |
| Jun 30, 2025 | 2.56 Mn |
| Jun 30, 2025 | 2.56 Mn |
| Mar 31, 2025 | -2.05 Mn |
| Mar 31, 2025 | -2.05 Mn |
| Dec 31, 2024 | 5.97 Mn |
| Dec 31, 2024 | 5.97 Mn |
| Sep 30, 2024 | 846,000.00 |
| Sep 30, 2024 | 846,000.00 |
| Jun 30, 2024 | 437,000.00 |
| Jun 30, 2024 | 437,000.00 |
| Mar 31, 2024 | -1.95 Mn |
| Mar 31, 2024 | -1.95 Mn |